Episode 3: Opeyemi Olabisi on APOL1-Mediated Kidney Disease and Community Engagement

01/11/24 • 15 min

We talk with Dr. Opeyemi Olabisi, MD, PhD, about the history and future of APOL1-mediated FSGS, the role of clinical researchers in building trust with patients, his innovative CARE and JUSTICE programs to bring kidney health screenings and research opportunities to the underrepresented African American community, and why his expertise as an MD/PhD in molecular biology led him to also become a leader in community engagement. The JAK-STAT pathway gets some love as well!

Dr. Olabisi's research and publications: https://medicine.duke.edu/profile/opeyemi-olabisi
More information on the CARE and JUSTICE studies: https://kidneycareandjustice.com/

Disclosures: Dr. Olabisi reports receiving research funding from NIH and Icagen, and consulting for Maze Therapeutics and Podium Bio.

01/11/24 • 15 min

GN in Ten - Episode 3: Opeyemi Olabisi on APOL1-Mediated Kidney Disease and Community Engagement

Transcript

Laurel Damashek00:00:00.909

Welcome to GN in Ten, a bite sized podcast brought to you by the International Society of Glomerular Disease. Our hosts are nephrologists and glomerular disease experts Dr. Kenar Jhaveri of Northwell Health and Hofstra University on Long Island, New York, and Dr. Koyal Jain from the University of North Carolina Chapel Hill.

Kenar Jhaveri00:00:25.903

Welcome everybody to GN in Ten. Today we have a special gues

Generate a badge

Get a badge for your website that links back to this episode

Select type & size

Copy